The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Population pharmacokinetics (PopPK) and exposure-response (ER) analyses to confirm the global alectinib (ALC) 600mg BID dose in the Chinese treatment-naïve population.
 
Joy Hsu
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Felix Jaminion
Employment - Roche
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Roche
 
Alice Shaw
Honoraria - Genentech/Roche; Ignyta; Novartis; Pfizer
Consulting or Advisory Role - ARIAD; Genentech/Roche; Ignyta; Novartis; Pfizer; Takeda
Research Funding - Genentech/Roche; Novartis; Pfizer
 
Caicun Zhou
No Relationships to Disclose
 
Tony Mok
Employment - The Chinese University of Hong Kong
Leadership - Sanomics Limited
Stock and Other Ownership Interests - Cirina; Sanomics Limited
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech
Consulting or Advisory Role - ACEA Biosciences; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Cirina; Clovis Oncology; geneDecode; Ignyta; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; Oncogenex; Pfizer; Roche/Genentech; SFJ Pharmaceuticals Group; Vertex
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Eisai (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); SFJ Pharmaceuticals Group (Inst); Taiho Pharmaceutical (Inst)
 
Tomohide Tamura
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb Japan; Chugai Pharma; Eisai; Kyowa Hakko Kirin; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical; Yakult Honsha
 
Tomohiro Tanaka
Employment - Chugai Pharma
 
Emmanuel Mitry
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Elena Guerini
Employment - Roche
Stock and Other Ownership Interests - GlaxoSmithKline; Roche
 
Eveline Nüesch
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Bogdana Balas
Employment - Novartis; Roche
Stock and Other Ownership Interests - Roche
 
Ali Hassan Zeaiter
Employment - Roche
Leadership - Roche
Stock and Other Ownership Interests - Roche
 
Peter N. Morcos
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Nicolas Frey
Employment - Roche
Stock and Other Ownership Interests - Roche
Travel, Accommodations, Expenses - Roche